Turn Therapeutics Inc Common Stock

Turn Therapeutics Inc Common Stock

Yahoo Finance • last month

Turn Therapeutics to Ring the Nasdaq Closing Bell on Monday, August 10, 2026

Turn Therapeutics Returns to Nasdaq to Highlight Its Progress Since Its October 2025 Direct Listing WESTLAKE VILLAGE, Calif., July 28, 2026--(BUSINESS WIRE)--Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company de... Full story

Yahoo Finance • 3 months ago

Top Biotech Gainers: TTRX Turns Heads, LIXT Shifts To AI Energy, CNXU Update, QTRX, TRAX On Watch

(RTTNews) - Monday's top gainers include Turn Therapeutics following its interim analysis findings from an atopic dermatitis study; Conexeu Science on progress in its B.R.E.A.S.T. bioprinting program; LIXTE Biotechnology and its strategic... Full story

Yahoo Finance • 5 months ago

Turn Therapeutics secures up to $25M in financing from Avenue Capital Group

* Turn Therapeutics (TTRX [https://seekingalpha.com/symbol/TTRX]) on Tuesday said it has entered into a growth capital loan facility with Avenue Venture Opportunities Fund II, a fund of Avenue Capital Group, for up to $25 million. * Th... Full story

Yahoo Finance • 10 months ago

Turn Therapeutics Inc. Non-GAAP EPS of -$0.07

* Turn Therapeutics Inc. press release [https://seekingalpha.com/pr/20306010-turn-therapeutics-reports-third-quarter-2025-financial-results-and-provides-corporate-updates] (TTRX [https://seekingalpha.com/symbol/TTRX]): Q3 Non-GAAP EPS of... Full story

Yahoo Finance • 10 months ago

Turn Therapeutics Appoints Veteran Capital Markets Executive Andrew Scott as Vice President of Corporate Communications

LOS ANGELES, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing dermatologic, advanced wound, and infectious disease therapies, today announced the appointment of An... Full story

Yahoo Finance • 10 months ago

Turn Therapeutics Provides Shareholder Update Highlighting Continued Execution Across Clinical and Strategic Milestones

WESTLAKE VILLAGE, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Turn Therapeutics (Nasdaq: TTRX) (“Turn” or the “Company”), a clinical-stage biotechnology company developing next-generation dermatology, wound, and anti-infective therapies, p... Full story

Yahoo Finance • 11 months ago

Turn Therapeutics Launches Webinar Series for Ongoing Shareholder Engagement, First Session October 22, 2025

LOS ANGELES, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Turn Therapeutics (Nasdaq: TTRX) today announced the launch of a broad communications initiative, featuring a recurring webinar series for shareholders and a forthcoming Founder Blog authore... Full story

Yahoo Finance • 11 months ago

Turn Therapeutics Appoints Arthur Golden to Board of Directors

Turn Therapeutics Veteran corporate advisor to strengthen governance, oversight, and strategic execution as the Company advances late-stage programs WESTLAKE VILLAGE, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Turn Therapeutics (“Turn” or... Full story